Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssaf-Harofeh Medical Center

About this trial

This study is a cross-over RCT evaluating the effectiveness of 3 sessions a week apart of explicit sensory retraining to the lower extremities in individuals with CIPN versus usual care. The primary outcome measures are TNAS for subjective symptoms, VAS for pain and TUG for mobility. Additional outcome measures are FABS for balance, sensory assessments - monofilaments for touch threshold, LEPT for proprioception, a home exercise log and a satisfaction questionnaire.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

CIPN by self-report (present or absent) > 3 months after last chemotherapy treatment

age > 18.

Disqualifiers

Pre-chemotherapy neuropathy/ sensory impairment

recurrent falls prior to chemotherapy (more than 2 per year)

CNS involvement

not ambulatory before chemotherapy

Trial design

Design model

Crossover

Treatments tested in this trial

  • Explicit Sensory Retraining for the lower extremities

    Other intervention

    Sensory retraining of detection, discrimination, quantification of a stimuli and recognition of stimuli and objects with the leg and mainly with the foot. Top-down awareness of bottom-up sensory experience in the treatment session and in everyday life.

  • no treatment

    Other intervention

    Usual care

Treatment groups

27 Participants
are divided into 2 treatment groups
Group A: AB - early experimental treatment, later control usual careOther 2 interventions
Group B: BA - early control usual care, later experimental treatmentOther 2 interventions

Trial outcomes

Primary outcomes

1

Patient self-Report Outcome Measure - Treatment-Induced Neuropathy Assessment Scale (TNAS)

TNAS -Treatment-Induced Neuropathy Assessment Scale: patient-reported outcome measure of presence and severity of CIPN. Nine 0-10 question scale. score 0-90. A higher score is for higher CIPN symptom severity.

Time frame
from randomization 3 months maximum
2

Functional - Balance and mobility outcome measure - Timed Up and Go test (TUG)

TUG -Timed Up and Go: Balance and mobility assessment. Serves as a fall prediction screening test. Measures time taken to raise from a chair walking 3 meters and re-sit.

Time frame
from randomization to maximum 3 months followup
3

Pain intensity: VAS - 0-100 mm visual scale

Pain intensity: VAS - 0-100 mm visual scale: self-reporting pain assessment from no pain to worst pain possible. We will ask for current pain and the worst pain during the last week

Time frame
from randomization to maximum 3 months

Secondary outcomes

1

Tactile function assessment - Semmes Weinstein Monofilaments (SWM)

Sensory threshold at the foot, as measured by Semmes Weinstein filaments.

Time frame
from randomization to maximum 3 months followup
2

FABS - Fullerton Advanced Balance Scale

FABS - Fullerton Advanced Balance Scale: high function balance test - consisting of 10 activities in both static and dynamic phases; 10-40, higher scores are better.

Time frame
from randomization to maximum 3 months
3

Proprioception of lower extremity: Lower Extremity Position Test (LEPT)

Proprioception of lower extremity as measured by Lower Extremity Position Test (LEPT).

Time frame
from randomization to maximum 3 months followup

Other outcomes

1

Home exercise log

Amount of home exercise per minutes per day

Time frame
1 minutes writing daily at home
2

Participant satisfaction questionnaire

Participant satisfaction questionnaire

Time frame
5 minutes, at final assessment session only

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assaf-Harofeh Medical Center

Lead sponsor

Zefat Academic College

Collaborator